DE50214184D1 - Transdermales therapeutisches system (tts) mit dem wirkstoff fentanyl - Google Patents

Transdermales therapeutisches system (tts) mit dem wirkstoff fentanyl

Info

Publication number
DE50214184D1
DE50214184D1 DE50214184T DE50214184T DE50214184D1 DE 50214184 D1 DE50214184 D1 DE 50214184D1 DE 50214184 T DE50214184 T DE 50214184T DE 50214184 T DE50214184 T DE 50214184T DE 50214184 D1 DE50214184 D1 DE 50214184D1
Authority
DE
Germany
Prior art keywords
fentanyl
active ingredient
active
transdermales
tts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE50214184T
Other languages
English (en)
Inventor
Walter Mueller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of DE50214184D1 publication Critical patent/DE50214184D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
DE50214184T 2001-08-24 2002-07-10 Transdermales therapeutisches system (tts) mit dem wirkstoff fentanyl Expired - Lifetime DE50214184D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10141651A DE10141651B4 (de) 2001-08-24 2001-08-24 Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
PCT/EP2002/007663 WO2003018071A1 (de) 2001-08-24 2002-07-10 Transdermales therapeutisches system (tts) mit dem wirkstoff fentanyl

Publications (1)

Publication Number Publication Date
DE50214184D1 true DE50214184D1 (de) 2010-03-11

Family

ID=7696569

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10141651A Expired - Lifetime DE10141651B4 (de) 2001-07-24 2001-08-24 Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
DE50214184T Expired - Lifetime DE50214184D1 (de) 2001-08-24 2002-07-10 Transdermales therapeutisches system (tts) mit dem wirkstoff fentanyl

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10141651A Expired - Lifetime DE10141651B4 (de) 2001-07-24 2001-08-24 Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung

Country Status (24)

Country Link
US (2) US7390500B2 (de)
EP (1) EP1418951B1 (de)
JP (1) JP4628673B2 (de)
KR (1) KR100895188B1 (de)
CN (1) CN100438859C (de)
AT (1) ATE455541T1 (de)
AU (1) AU2002321199B2 (de)
BR (1) BRPI0212028B8 (de)
CA (1) CA2457245C (de)
CY (1) CY1109954T1 (de)
DE (2) DE10141651B4 (de)
DK (1) DK1418951T3 (de)
ES (1) ES2339640T3 (de)
HK (1) HK1069534A1 (de)
HU (1) HU229942B1 (de)
IL (2) IL160515A0 (de)
MX (1) MXPA04001679A (de)
NZ (1) NZ530795A (de)
PL (1) PL204348B1 (de)
PT (1) PT1418951E (de)
RU (1) RU2311908C2 (de)
TW (1) TW570815B (de)
WO (1) WO2003018071A1 (de)
ZA (1) ZA200400473B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US20040086551A1 (en) 2002-10-30 2004-05-06 Miller Kenneth J. Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
CA2513402A1 (en) * 2003-02-07 2004-08-19 Walter Mueller Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof
BRPI0318250B8 (pt) * 2003-04-14 2021-05-25 Lts Lohmann Therapie Systeme Ag emplastro tópico com matriz de polissiloxano e método para a produção de preparação de um emplastro tópico
US20110086086A1 (en) * 2005-07-26 2011-04-14 Pfizer Inc Transdermal system for varenicline
DE102006019293A1 (de) * 2006-04-21 2007-10-25 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Pflaster, enthaltend ein Fentanyl Analogum
GB0615429D0 (en) * 2006-08-03 2006-09-13 Chowdhury Dewan F H Transdermal drug delivery with temporal control
DE102006054731B4 (de) 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
DE102006054732B4 (de) 2006-11-21 2010-12-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren
DE102008016804B4 (de) * 2008-04-02 2012-01-05 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System mit verbesserter Funktionalität und Wirksamkeit sowie seine Verwendung
US20100221313A1 (en) * 2008-12-01 2010-09-02 Innovative Pharmaceuticals, Llc Transdermal reservoir patch
KR101738650B1 (ko) * 2009-07-21 2017-05-22 밀란 인크. 폴리이소부틸렌계 경피 패치의 연속 제조 방법
US9822088B2 (en) 2011-03-30 2017-11-21 The United States Of America As Represented By The Administrator Of Nasa Anisotropic copoly(imide oxetane) coatings and articles of manufacture, copoly(imide oxetane)s containing pendant fluorocarbon moieties, oligomers and processes therefor
DE102011080390B3 (de) * 2011-08-03 2012-07-12 Acino Ag Applikationshilfe
MX352795B (es) 2011-12-12 2017-12-07 Lts Lohmann Therapie Systeme Ag Sistema de administracion transdermica que comprende buprenorfina.
TW201431570A (zh) * 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
EA201592246A1 (ru) * 2013-06-04 2016-05-31 Лтс Лохманн Терапи-Системе Аг Трансдермальная система доставки
EP3016641B1 (de) 2013-07-03 2018-09-05 LTS Lohmann Therapie-Systeme AG Transdermales therapeutisches system mit elektronischem bauteil
EP3145504B1 (de) 2014-05-20 2023-07-26 LTS Lohmann Therapie-Systeme AG Transdermales abgabesystem mit einem schnittstellenmediator
JP6573913B2 (ja) 2014-05-20 2019-09-11 エルテーエス ローマン テラピー−ジステーメ アーゲー ロチゴチンを含む経皮送達システム
WO2015177209A1 (en) 2014-05-20 2015-11-26 Lts Lohmann Therapie-Systeme Ag Method for adjusting the release of active agent in a transdermal delivery system
US9962340B2 (en) 2015-06-09 2018-05-08 Life Tech Global, Llc Device and method for the transdermal delivery of cannabidiol
US10272125B2 (en) * 2015-09-14 2019-04-30 Life Tech Global, Llc Transdermal delivery of cannabidiol with other active moieties including cannabinoids
US9650338B1 (en) 2016-07-29 2017-05-16 VDM Biochemicals, Inc. Opioid antagonist compounds and methods of making and using
DE102017107468B4 (de) * 2017-04-06 2019-02-21 Lts Lohmann Therapie-Systeme Ag Verfahren zur herstellung eines, insbesondere oralen, wirkstofflaminats und wirkstofflaminat, insbesondere orales wirkstofflaminat
IL269957B (en) 2017-04-18 2022-08-01 Breakthrough Tech Llc Sulfur production
CN111093638B (zh) * 2017-09-04 2024-03-26 罗曼治疗系统股份公司 包含乳化剂的透皮递送系统
JP6912122B2 (ja) * 2019-02-28 2021-07-28 日本臓器製薬株式会社 経皮投与製剤

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310559A (en) * 1982-09-01 1994-05-10 Hercon Laboratories Corporation Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
US6110488A (en) * 1986-08-28 2000-08-29 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
US4906463A (en) 1986-12-22 1990-03-06 Cygnus Research Corporation Transdermal drug-delivery composition
US4822802A (en) * 1987-02-24 1989-04-18 Alza Corporation Method of fentanly administration for postoperative pain relief
US4849224A (en) * 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa
FR2623718B1 (fr) * 1987-11-27 1994-04-15 Fabre Medicament Pierre Dispositif therapeutique transdermique et son procede de preparation
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE3905051A1 (de) * 1989-02-18 1990-08-30 Lohmann Therapie Syst Lts Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (i)
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
JP3202777B2 (ja) * 1992-01-24 2001-08-27 リンテック株式会社 経皮吸収促進剤及びテープ製剤
ES2115231T3 (es) * 1993-04-20 1998-06-16 Hexal Ag Emplasto con sustancias activas.
CN1094972A (zh) * 1993-05-21 1994-11-16 深圳广信生物工程公司 控释透皮治疗系统及其制备与应用
JP3240496B2 (ja) * 1993-09-30 2001-12-17 タキロン株式会社 経皮吸収製剤
US5665378A (en) * 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
JP4346696B2 (ja) * 1996-05-28 2009-10-21 久光製薬株式会社 経皮治療用装置
DE19728517C2 (de) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung
KR19980025307A (ko) * 1998-04-11 1998-07-06 조태임 진통효과를 갖는 약물의 경피흡수제제
US6312715B1 (en) * 1998-05-01 2001-11-06 3M Innovative Properties Company Adhesive microsphere drug delivery composition
CZ301726B6 (cs) * 1999-07-02 2010-06-02 Lts Lohmann Therapie-Systeme Ag Mikrorezervoárový systém na bázi polysiloxanu a ambifilních rozpouštedel
DE19958554C2 (de) * 1999-07-02 2002-06-13 Lohmann Therapie Syst Lts Mikroreservoirsystem auf Basis von Polysiloxanen und ambiphilen Lösemitteln und ihre Herstellung
US6893655B2 (en) * 2001-10-09 2005-05-17 3M Innovative Properties Co. Transdermal delivery devices

Also Published As

Publication number Publication date
HUP0401512A3 (en) 2012-08-28
RU2311908C2 (ru) 2007-12-10
ATE455541T1 (de) 2010-02-15
BR0212028A (pt) 2004-08-03
US7390500B2 (en) 2008-06-24
HUP0401512A2 (hu) 2004-12-28
ZA200400473B (en) 2004-10-14
DE10141651B4 (de) 2007-02-15
DK1418951T3 (da) 2010-05-10
IL160515A0 (en) 2004-07-25
TW570815B (en) 2004-01-11
DE10141651A1 (de) 2003-03-13
BRPI0212028B8 (pt) 2021-05-25
AU2002321199B2 (en) 2007-08-16
EP1418951B1 (de) 2010-01-20
JP4628673B2 (ja) 2011-02-09
NZ530795A (en) 2005-08-26
RU2004108849A (ru) 2005-05-10
JP2005501865A (ja) 2005-01-20
EP1418951A1 (de) 2004-05-19
KR100895188B1 (ko) 2009-04-24
CA2457245A1 (en) 2003-03-06
CY1109954T1 (el) 2012-05-23
US20040234583A1 (en) 2004-11-25
HU229942B1 (en) 2015-01-28
MXPA04001679A (es) 2004-05-31
IL160515A (en) 2009-09-22
US20080274167A1 (en) 2008-11-06
PT1418951E (pt) 2010-04-07
BRPI0212028B1 (pt) 2020-11-24
HK1069534A1 (de) 2005-05-27
CN100438859C (zh) 2008-12-03
CN1545407A (zh) 2004-11-10
WO2003018071A1 (de) 2003-03-06
ES2339640T3 (es) 2010-05-24
PL204348B1 (pl) 2010-01-29
PL366857A1 (en) 2005-02-07
KR20040029021A (ko) 2004-04-03
CA2457245C (en) 2010-09-07

Similar Documents

Publication Publication Date Title
DE50214184D1 (de) Transdermales therapeutisches system (tts) mit dem wirkstoff fentanyl
AU2002321199A1 (en) Transdermal therapeutic system (TTS) with fentanyl as active ingredient
ES2176234T3 (es) Sistema terapeutico transdermal con galantamina como componente activo.
ATE369125T1 (de) Bioadhäsiver schaumstoffilm mit hinhaltender wirkstoffreigabe
AR097045A2 (es) Sistema terapéutico transdérmico
ATE342097T1 (de) Elektroaktive pore
HRP20050828B1 (hr) Uv-stabilni transdermalni flaster
WO2001068060A3 (de) Stabilisierte übersättigte transdermale therapeutische matrixsysteme
MXPA04001676A (es) Sistema terapeutico transdermico con fentanilo o sustancias relacionadas.
ATE396714T1 (de) Transdermales therapeutisches system mit verbessertem langzeittragekomfort
AR028525A1 (es) Sistema terapeutico transdermal para la administracion de lerisetron
DK1143938T3 (da) Transdermalt terapeutisk system med en selvklæbende matrix, der indeholder organiske syreadditionssalte af alkaloider af morphin- eller morphin-type
WO2001026637A3 (de) Transdermales therapeutisches system zur abgabe von acetylsalicylsäure und/oder salicylsäure
ATE293442T1 (de) Desoxypeganin-tts
DE59910944D1 (de) Transdermales therapeutisches system zur anwendung von candesartan
AR037405A1 (es) Sistema terapeutico transdermal para la administracion de 17alfa-estradiol

Legal Events

Date Code Title Description
8364 No opposition during term of opposition